When specified cut-offs were used, accurate subject assignments between the CON and HCC groups with the following criteria – “ALT of >10.50 IU/ml OR ApoA1>0.7673 mg/ml” had respective sensitivity and specificity values of 82.5% and 74.5%. This evidence concerns the gene GPT and hepatocellular carcinoma.